Problem
Topic is: Transfer of a developed Covid vaccine from a European based pharmaceutical manufacturer to a European based contract Manufacturing Organisation (CMO).
Initiate: Identify a high-end overview of the requirements, gaps and risks involved in the TT from the European based pharmaceutical manufacturer to a European based CMO
1. Sending and receiving site information required
2. What are the Validation Master Plan (VMP) main areas of focus such as facilities, personnel & cleaning etc
3. Outline the potential gaps and risks with the TT in the VMP areas mentioned above.